Method and composition for selective treatment of androgen receptors
An improved method of promoting hair growth includes the use of one or more photosensitive curcuminoids, provided in combination with other hair growth components and preferably solubilized in bio-compatible materials to create a nano-particulate. These materials are introduced via fractional topical delivery and subsequently activated by exposure to specific wavelengths of light. This sequence results in improved hair growth in comparison to previously known methods, and the use of photosensitive curcuminoids in this manner may be employed to treat other skin disorders.
1. A method for promoting hair growth comprising:
selecting one or more photosensitive curcuminoids;
combining the one or more photosensitive curcuminoids in a bio-compatible form to create a solubilized curcuminoid;
applying the solubilized curcuminoid, in combination with one or more hair growth factors and/or peptides, to a targeted area of intraepidermal layer of human skin without ingestion and without uptake into any blood vessels that are in and immediately adjacent to the targeted area; and
exposing the targeted area to a light source for a period of time that is effective to excite the one or more photosensitive curcuminoids.
2. The method according to claim 1 wherein mechanical or energetic fractional topical treatment precedes the applying the solubilized curcuminoid to the targeted area.
3. The method according to claim 1 wherein the light source has a wavelength between 600 and 900 nanometers.
4. The method according to claim 1 wherein at least two chemically distinct photosensitive curcuminoids are selected.
5. The method according to claim 1 wherein the one or more photosensitive curcuminoids are at least one selected from the group consisting of: curcumin, dimethylcurcumin, demethoxycurcumin, and bis-demethoxycurcumin.
6. The method according to claim 1 wherein the hair growth factors and/or peptides are encapsulated in a nanoliposomal formulation with the one or more photosensitive curcuminoids.
7. The method according to claim 1 wherein the solubilized curcuminoid has a diameter no larger than 300 microns.
8. The method according to claim 1 wherein the solubilized curcuminoid are applied by way of mechanical fractional topical delivery including the use of one or more intraepidermal needles at an intraepidermal penetration of between 50 to 300 micrometers.
9. The method according to claim 1 wherein the solubilized curcuminoid are applied by way of energetic fractional topical delivery and the light source emits only red and/or infrared wavelengths of light.
10. The method according to claim 1 wherein the exposing the treated area occurs within less than one hour after the applying the solubilized curcuminoid.
11. The method according to claim 2 wherein the applying the solubilized curcuminoid to the targeted area occurs within less than one hour after the mechanical or energetic fractional topical treatment.
12. The method according to claim 1 wherein the bio-compatible form is selected from the group consisting of: free solutes, polymeric micelles, polymeric/phospholipid composites, colloidal nanoparticles, and nanoliposomes.
13. The method according to claim 1 wherein the solubilized curcuminoid and the one or more hair growth factors and/or peptides are provided in a deformable vesicle.
14. The method according to claim 13 wherein the deformable vesicle includes at least one edge activator.
15. The method according to claim 13 wherein the deformable vesicle includes at least one penetration enhancer.
16. The method according to claim 1 wherein the hair growth factors and/or peptides are encapsulated in a nanoliposomal formulation.
17. A method for treating selected areas of skin to mitigate militate unwanted effects of localized androgens present therein, the method comprising:
selecting one or more photosensitive curcuminoids;
formulating the one or more photosensitive curcuminoids with one or more hair growth factors and/or peptides to create a photo-activated treatment compound;
introducing the photo-activated treatment compound to a targeted intraepidermal layer of skin positioned between a surface layer of stratum corneum and a base layer of dermis by way of microchannels penetrating beyond stratum corneum, with the microchannels configured to avoid pain receptors in the dermis;
wherein the introducing the photo-activated treatment does not include: i) ingestion of the photo-activated compound, and ii) uptake of the photo-activated treatment into any blood vessels that are in, above, below, or surrounding the targeted intraepidermal layer;
wherein the formulating produces a photo-activated treatment compound having compatibility for passage through the microchannels; and
exposing the surface layer immediately above the targeted intraepidermal layer to a light source for a period of time that is effective to excite the one or more photosensitive curcuminoids.
18. The method according to claim 17 wherein the introducing the photo-activated treatment compound includes mechanical creation of the microchannels by way of dilation, pressure, and/or temporarily puncturing the stratum corneum.
19. The method according to claim 17 wherein the introducing the photo-activated treatment compound includes energetic creation of the microchannels by way of electrical current, sonic energy, and/or electromagnetic radiation.